tiprankstipranks
Advertisement
Advertisement
Jazz Pharmaceuticals price target raised to $226 from $225 at Deutsche Bank
PremiumThe FlyJazz Pharmaceuticals price target raised to $226 from $225 at Deutsche Bank
1M ago
Jazz Pharmaceuticals Balances Record Gains With Slower 2026
Premium
Company Announcements
Jazz Pharmaceuticals Balances Record Gains With Slower 2026
1M ago
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
Premium
The Fly
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
1M ago
Jazz Pharmaceuticals price target raised to $250 from $235 at Wells Fargo
PremiumThe FlyJazz Pharmaceuticals price target raised to $250 from $235 at Wells Fargo
2M ago
Jazz Pharmaceuticals: Underappreciated Growth Story with Durable Sleep Franchise and Pipeline-Driven Upside
Premium
Ratings
Jazz Pharmaceuticals: Underappreciated Growth Story with Durable Sleep Franchise and Pipeline-Driven Upside
2M ago
Jazz Pharmaceuticals reports Q4 adjusted EPS $6.64 vs. $6.51 last year
Premium
The Fly
Jazz Pharmaceuticals reports Q4 adjusted EPS $6.64 vs. $6.51 last year
2M ago
Jazz Pharmaceuticals price target raised to $230 from $220 at Truist
PremiumThe FlyJazz Pharmaceuticals price target raised to $230 from $220 at Truist
3M ago
Jazz Pharmaceuticals price target raised to $235 from $210 at Needham
Premium
The Fly
Jazz Pharmaceuticals price target raised to $235 from $210 at Needham
3M ago
Jazz Pharmaceuticals price target raised to $235 from $210 at Needham
Premium
The Fly
Jazz Pharmaceuticals price target raised to $235 from $210 at Needham
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100